Literature DB >> 20536843

Transcriptome analysis and tumor suppressor requirements of STAT5-induced senescence.

Frédérick A Mallette1, Olga Moiseeva, Viviane Calabrese, Botum Mao, Marie-France Gaumont-Leclerc, Gerardo Ferbeyre.   

Abstract

Although it is acknowledged that senescent cells accumulate with age, the molecular mechanisms leading to cell senescence as a function of age remain to be identified. In cell culture models, it has been clearly shown that senescence involves the activation of a DNA damage response secondary to short telomeres or oncogene expression. Oncogenes are altered versions of genes coding for proteins that mediate signals from extracellular factors such as cytokines, growth factors, and hormones. In particular, we show here that constitutive activation of the JAK/STAT5 signaling pathway induces senescence in both mouse and human normal cells. The process involves activation of the p53 and Rb tumor suppressor pathways and mitochondrial dysfunction. Gene expression analysis of STAT5-induced senescence revealed changes in the expression of genes coding for cytokines, proteins in cytokine signaling pathways, and several metabolic enzymes. We discuss a model called senescence-induced senescence, in which cytokines secreted by senescent cells can propagate the process as a function of age.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20536843     DOI: 10.1111/j.1749-6632.2010.05192.x

Source DB:  PubMed          Journal:  Ann N Y Acad Sci        ISSN: 0077-8923            Impact factor:   5.691


  5 in total

1.  SOCS1, a novel interaction partner of p53 controlling oncogene-induced senescence.

Authors:  Frédérick A Mallette; Viviane Calabrese; Subburaj Ilangumaran; Gerardo Ferbeyre
Journal:  Aging (Albany NY)       Date:  2010-07       Impact factor: 5.682

Review 2.  STAT3 and STAT5 Activation in Solid Cancers.

Authors:  Sebastian Igelmann; Heidi A Neubauer; Gerardo Ferbeyre
Journal:  Cancers (Basel)       Date:  2019-09-25       Impact factor: 6.639

3.  STAT5 triggers BCR-ABL1 mutation by mediating ROS production in chronic myeloid leukaemia.

Authors:  Wolfgang Warsch; Eva Grundschober; Angelika Berger; Lars Gille; Sabine Cerny-Reiterer; Anca-Sarmiza Tigan; Andrea Hoelbl-Kovacic; Peter Valent; Richard Moriggl; Veronika Sexl
Journal:  Oncotarget       Date:  2012-12

Review 4.  The Histone Code of Senescence.

Authors:  Harikrishnareddy Paluvai; Eros Di Giorgio; Claudio Brancolini
Journal:  Cells       Date:  2020-02-18       Impact factor: 6.600

5.  The oncometabolite 2-hydroxyglutarate activates the mTOR signalling pathway.

Authors:  Mélissa Carbonneau; Laurence M Gagné; Marie-Eve Lalonde; Marie-Anne Germain; Alena Motorina; Marie-Christine Guiot; Blandine Secco; Emma E Vincent; Anthony Tumber; Laura Hulea; Jonathan Bergeman; Udo Oppermann; Russell G Jones; Mathieu Laplante; Ivan Topisirovic; Kevin Petrecca; Marc-Étienne Huot; Frédérick A Mallette
Journal:  Nat Commun       Date:  2016-09-14       Impact factor: 17.694

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.